DateNov. 24(Wed) 08:30~15:30
PlaceLotte Hotel Seoul, Sapphire Ballroom,(3F) Seoul, Korea & Live Streaming on YouTube
OrganizersNews1
08:00~08:30 |
Registration & VIP conversation |
|
08:30~09:00 |
Opening
Greetings |
Baik Kyu Lee CEO, News1 Min Seok Kim Chairman, Health and Welfare committee, National Assembly Ganglip KimMinister, Ministry of Food and Drug Safety Hongtaek Yong 1st Vice-Minister, Ministry of Science and ICT |
09:00~09:30 |
Key note Speech 1With COVID-19, how will our daily lives change? & How will treatments and vaccines be applied? - LIVE Streaming |
Robert R. Redfieldformer CDC Director |
09:30~10:00 |
1:1 discussion - LIVE streaming &offline site combined |
Robert R. Redfieldformer CDC Director Ki Suck, JungProfessor of Pulmonary at Hallym University Sacred Heart Hospital |
10:00~10:30 |
Key note Speech 2Task of 'K-Bio' in the era of with COVID-19 |
Hyunsang MukCEO, Korea Drug Development Fund |
10:30~11:00 |
SessionReimagining new ground in cancer treatment : Present and future of CAR-T - LIVE Streaming |
Hyungwook LimSr. Principal Scientist, Cell Therapy Lab at Novartis Institutes for BioMedical (NIBR) |
11:00~11:20 |
SessionCOVID-19 vaccine platform and the development of new anticancer drugs - Streaming(pre-recorded) |
Bill EnrightCEO, Vaccitech |
11:20~11:50 |
SessionK-Bio. Requirements for taking the lead, 'M&A' |
Donghoon LeeExecutive Vice President, SK Holdings(Bio investment Center) |
11:50~12:10 |
SessionM&A, K-Bio Venture's growth catalyst |
Jisoo PaeCEO, Genome & Company |
12:10~13:30 |
Lunch |
|
13:30~14:00 |
SessionAttention from the world, Samsung Biologics' global CDMO strategy |
James ChoiDirector, Global Information Marketing Center at SamsungBiologics |
14:00~15:30 |
IR Session |
Bridgebiotherapeutics Eyebiokorea Toogene Inventagelab Genemedicine |
Closing |
※ The above schedule is subject to change.